Skip to main content
Clinical Trials/NCT05201313
NCT05201313
Completed
Phase 3

Randomised Controlled Trial to Evaluate the Efficacy of Local Anaesthetic Application in Spray for the Repair of 1st- 2nd Perineal Lacerations Following Vaginal Delivery

Azienda Sanitaria-Universitaria Integrata di Udine1 site in 1 country136 target enrollmentJanuary 20, 2022

Overview

Phase
Phase 3
Intervention
Lidocaine Hydrochloride
Conditions
Vaginal Discharge
Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Enrollment
136
Locations
1
Primary Endpoint
NRS o
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Randomized controlled trial aimed at evaluating the efficacy and safety of the use of a local anesthetic spray, commonly used in clinical practice as off-label, during the suturing of perineal lacerations in post-partum, comparing it with the standard technique that involves the infiltration of lacerated tissues, by administering a NRS card at the end of the procedure.

Detailed Description

The study aims to compare the effectiveness of pain treatment during the suturing of postpartum perineal lacerations with lidocaine spray vs skin infiltration. The hypothesis of the study is that the treatment of perineal pain with nebulization demonstrates comparable efficacy vs the infiltration of mepivacaine hydrochloride in a population of patients subjected to suturing of postpartum lacerations. Eligible women will be randomly assigned to receive, after wound disinfection and cleansing of bleeding with mild haemostasis: 1. nebulization 3 puffs of 10 mL Lidocaine hydrochloride 10% spray at a distance of 4-5 cm (experimental group). 2. subcutaneous / submucosal infiltration depending on the type of perineal laceration of 10 ml of 1% mepivacaine hydrochloride (control group). Since there are no previous published studies, regarding the use of nebulized lidocaine hydrochloride for the suturing of perineal lacerations, the number of puffs chosen was chosen based on what is indicated on the technical data sheet of lidocaine hydrochloride and making use of previous studies in the gynecological field, but with other indications. The suture will be made once anesthetic efficacy is achieved, as per pharmacological indications. The administration of the anesthetic and the suturing of the lacerations will be performed by the gynecologist or by the gynecology resident who will be working at that time in the delivery room, as is routinely done in our Clinic. The patients will be enrolled consecutively following the order generated by the randomization list itself. By filling in specific pre-set cards, the data will be collected. Initially, the primary outcome was NRS at the beginning of suturing and NRS at the end of the procedure. In a second moment, the investigators thought it would be better to ensure that adequate analgesia (NRS\<4) was achieved for all patients during suturing, rather than varying the dosage of the anesthetic itself. The investigators then decided to reassess pain at successive time points, evaluating it at 0, 2, 4, 12, and 24 hours.

Registry
clinicaltrials.gov
Start Date
January 20, 2022
End Date
August 8, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stefano Restaino

Principal Investigator

Azienda Sanitaria-Universitaria Integrata di Udine

Eligibility Criteria

Inclusion Criteria

  • have a 1st or 2nd degree postpartum perineal laceration requiring suturing;
  • have reached 37 gestational weeks;
  • are over 18 years of age;
  • had a top birth;
  • are able to understand the Italian language;
  • have a consent to participate in the study;

Exclusion Criteria

  • have received epidural anesthesia within 2 hours prior to delivery;
  • had an operative birth;
  • have a psychiatric pathology;
  • have had a twin birth;
  • have experienced adverse reactions to any local anesthetic in the past;
  • hypersensitivity to the active substance or to any of the excipients
  • Severe disturbances of the cardiac conduction system
  • Acute non compensated heart failure
  • Severe arteriopathies
  • Severe uncontrolled hypertension

Arms & Interventions

lidocaine spray

nebulization 3 puffs of 10 mL Lidocaine hydrochloride 10% spray at a distance of 4-5 cm

Intervention: Lidocaine Hydrochloride

mepivacaine infiltration

subcutaneous / submucosal infiltration depending on the type of perineal tear of 10 ml of 1% mepivacaine hydrochloride

Intervention: Mepivacaine Injection

Outcomes

Primary Outcomes

NRS o

Time Frame: during suturing

numeric rating scale for pain (0=no pain-10=maximum pain)

NRS 24

Time Frame: At 24 hours after delivery

numeric rating scale for pain (0=no pain-10=maximum pain)

NRS 2

Time Frame: At 2 hours after delivery

numeric rating scale for pain (0=no pain-10=maximum pain)

NRS 4

Time Frame: At 4 hours after delivery

numeric rating scale for pain (0=no pain-10=maximum pain)

NRS 12

Time Frame: At 12 hours after delivery

numeric rating scale for pain (0=no pain-10=maximum pain)

Secondary Outcomes

  • need for additional doses (number of additional nebulizations, presence or absence of additional infiltration)(during the suture)
  • final satisfaction, assessed via telephonic interview(30 days follow up)

Study Sites (1)

Loading locations...

Similar Trials